Early trial tests 'Off-the-Shelf' cell therapy for tough lymphoma
NCT ID NCT07248163
Summary
This is an early-stage study testing a new type of cell therapy called universal CAR-T for adults with B-cell Non-Hodgkin Lymphoma that has come back or not responded to other treatments. The main goal is to check if the treatment is safe and see if it helps control the cancer. It's a small study at a single center, enrolling 3 to 6 people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA,B CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Shanghi Tongji Hospital (Tongji Hospital of Tongji University)
RECRUITINGShanghai, 620000, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.